Reuters logo
BRIEF-Cryoport to support commercial launch of Kite Pharma's CAR-T therapy, axi-cel​
September 5, 2017 / 12:52 PM / 3 months ago

BRIEF-Cryoport to support commercial launch of Kite Pharma's CAR-T therapy, axi-cel​

Sept 5 (Reuters) - Cryoport Inc

* Cryoport Inc - ‍Cryoport selected to support potential commercial launch of Kite Pharma’s CAR-T Therapy Axicabtagene Ciloleucel​

* Cryoport Inc - ‍will provide logistics support throughout United States in accordance with Kite’s plans for patient adoption of axi-cel​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below